Previous studies with clinically applicable vectors have been limited to the use of DBA mouse models (21–23) or to the evaluation of the response of RPS19-interfered HSCs from HDs (23, 24), which do not accurately replicate the HSC defects characteristic of patients with DBA. The gene discussed is RPS19; the disease is Diamond-Blackfan anemia.